Home / Inspections / 1003671

FDA Inspection 1003671 — Batzofin Fertility Services d.b.a. New York Fertility Services

Batzofin Fertility Services d.b.a. New York Fertility Services — FEI 3007196536

The FDA completed an inspection of Batzofin Fertility Services d.b.a. New York Fertility Services on February 16, 2017 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 16, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1087800 (VAI Mon Apr 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 925090 (NAI Wed May 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 830634 (VAI Fri May 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 724607 (VAI Thu May 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources